Jen Deese is an Epidemiologist in the Contraceptive Technology and Innovation Department (CTID) at FHI 360. She joined FHI 360 in 2001 and has more than fifteen years of experience managing and designing international clinical research studies, including five phase-3 trials of biomedical interventions for HIV prevention among women.
Her expertise is in (1) hormonal contraception, (2) female genital tract immunity as it relates to HIV acquisition, (3) biomedical HIV prevention, and (4) research design.
Deese has a PhD in Epidemiology with a concentration in infectious disease, and an MPH in Maternal and Child Health — both from The University of North Carolina at Chapel Hill.
- Deese J, Masson L, Miller W, Cohen M, Morrison C, Wang M, Ahmed K, Agot K, Crucitti T, Abdellati S, Van Damme L. Injectable progestin-only contraception is associated with increased levels of pro-inflammatory cytokines in the female genital tract. Am J Reprod Immunol. 2015 Oct;74(4):357-67.
- Corneli A, Deese J, Wang M, Taylor D, Ahmed K, Agot K, Lombaard J, Manongi R, Kapiga S, Kashuba A, Van Damme L, for the FEM-PrEP Study Group. FEM-PrEP: Adherence patterns and factors associated with adherence to a daily, oral study product for pre-exposure prophylaxis. JAIDS. 2014; 66(3): 324-331.
- Todd K, Deese J, Wang M, Steiner M, Taylor D. Plasma levonorgestrel levels over time in Sino-Implant II users: a sub-analysis of FEM-PrEP cohort data. Contraception. 2015 Mar;91(3):248-52.
- Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, Malahleha M, Owino F, Manongi, R, Onyango J, Temu L, Monedi MC, Mak’Oketch P, Makanda M, Reblin I, Makatu SE, Saylor, L, Kiernan H, Kirkendale S, Wong C, Grant R, Kashuba A, Nanda K, Mandala J, Fransen K, Deese J, Crucitti T, Mastro TD, Taylor D. Preexposure Prophylaxis for HIV Infection among African Women. New England Journal of Medicine 2012; 367 (5): 411-22.
- Van Damme L, Govinden R, Mirembe F, Guédou F, Solomon S, Becker M, Pradeep B.S., Krishnan A. K. Alary M, Pandey B, Ramjee G, Deese J, Crucitti T, Taylor D. Lack of Effectiveness of Cellulose Sulfate Gel for the Prevention of Vaginal HIV Transmission. New England Journal of Medicine 2008; 359 (5): 463-472.